Sequential Change of Hypometabolic Metastasis from Non-small-cell Lung Cancer on Brain FDG-PET/CT

연속적인 FDG-PET/CT 검사에서 섭취 감소로 관찰된 비소세포암의 뇌전이

  • Park, Soon-Ah (Department of Nuclear Medicine, Wonkwang University College of Medicine) ;
  • Yang, Sei-Hoon (Department of Internal Medicine, Wonkwang University College of Medicine) ;
  • Yang, Chung-Yong (Department of Physical Medicine and Rehabilitation, Wonkwang University College of Medicine) ;
  • Choi, Keum-Ha (Department of Pathology, Wonkwang University College of Medicine)
  • 박순아 (원광대학교 의과대학 핵의학과) ;
  • 양세훈 (원광대학교 의과대학 내과) ;
  • 양충용 (원광대학교 의과대학 재활의학과) ;
  • 최금하 (원광대학교 의과대학 병리과)
  • Published : 2009.10.31

Abstract

A 60-year-old woman, who had non-small-cell lung cancer (NSCLC) in left lower lobe underwent brain F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for evaluation of cerebral metastasis. On follow-up FDG-PET/CT, only hypometaolic lesion was detected and progressed in right frontal lobe at 6 months and 10 months, later. Hypermetabolic metastasis was not detected even at last scan time of FDG-PET/CT. Brain MRI showed brain metastasis in right frontal lobe. As might be expected, the physician should take cerebral metastasis into consideration even though there is only hypometabolic change on subsequent FDG-PET/CT in patients with NSCLC.

Keywords